[AIDS-related early mortality in Mexico between 2008 and 2012]

Salud Publica Mex. 2015:57 Suppl 2:s119-26.
[Article in Spanish]

Abstract

Objective: To describe the distribution of AIDS-related mortality according to the time of occurrence since entry to the System for the Administration, Logistics and Surveillance of Antiretrovirals (SALVAR, in Spanish), among users of Ministry of Health facilities in Mexico.

Materials and methods: Descriptive analysis of AIDS mortality and the related clinical and demographic profile of 41847 patients registered in SALVAR.

Results: 3195 patients (8.1%) died within the study period, 59% of these deaths occurred within six months after treatment initiation. Among those patients, 87.3% were diagnosed late, given their CD4 levels (CD4cel<200 cel/ml³).

Conclusion: Our results underscore the need to strengthen programs aimed to increase opportune HIV diagnosis and linkage to care, as a key component of universal access policy to antiretroviral treatment in Mexico.

MeSH terms

  • Acquired Immunodeficiency Syndrome / mortality*
  • Adult
  • Ambulatory Care Facilities
  • Anti-HIV Agents / therapeutic use
  • Delayed Diagnosis
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • Health Services Accessibility
  • Health Services Needs and Demand
  • Humans
  • Male
  • Mexico / epidemiology
  • Mortality, Premature / trends*
  • National Health Programs
  • Registries
  • Retrospective Studies
  • Social Determinants of Health
  • Universal Health Insurance

Substances

  • Anti-HIV Agents